In discussions about cancer-related nutrition and supportive therapies, “antioxidants” are frequently mentioned. Among them, glutathione is one of the body’s most important endogenous antioxidants.
Many patients hear about glutathione during treatment, yet fewer fully understand how it functions in the body and when supplementation may or may not be appropriate.
Vitamin D is one of the most frequently discussed nutrients in cancer-related nutrition.
Beyond its well-known role in bone health, vitamin D is also involved in immune regulation, cellular differentiation, and inflammatory balance. For this reason, many patients undergoing treatment or in recovery begin to wonder:
Am I deficient in vitamin D? Should I be supplementing?
Among supportive therapies discussed in the context of cancer care, high-dose vitamin C intravenous (IV) therapy remains one of the most debated options.
Some believe it may help improve fatigue or overall vitality, while others question whether it could interfere with primary treatments. In a landscape filled with mixed information, the key is not to take sides—but to understand its biological rationale and appropriate clinical context.
During cancer treatment, inflammation is almost always part of the physiological picture.
The tumor itself, chemotherapy, radiation therapy, and even prolonged psychological stress can all contribute to a state of chronic inflammation.
When inflammation persists, patients may experience:
• Ongoing fatigue
• Reduced appetite
• Muscle loss
• Weight fluctuations
• Unstable immune function
For this reason, managing inflammatory balance—without interfering with primary treatment—has become an important area of supportive care.
After completing major cancer treatments, many patients notice a disconnect:
Medical reports may appear stable, yet their physical strength does not seem to return.
Shortness of breath while walking, reduced concentration, persistent fatigue, and difficulty handling daily activities are common concerns. This slower-than-expected recovery is not unusual in clinical practice.
Often, the issue is not simply general weakness — it may be related to nutritional status and red blood cell function.
During cancer treatment, the body is not only coping with the disease itself but also with the metabolic stress and side effects caused by surgery, chemotherapy, or radiation therapy.
Throughout this process, certain vitamins may be depleted more quickly, absorbed less efficiently, or consumed in lower amounts due to dietary changes.
As a result, the risk of vitamin deficiencies is often higher than in the general population.
During cancer treatment, many people focus heavily on medications, side effects, and test results, yet often overlook one fundamental yet critical factor — protein intake.
In reality, during both the treatment phase and recovery period, protein is not just “part of nutrition” — it is a core building block for the body’s repair and maintenance of essential functions.
When treatment ends, many people naturally expect that things will steadily improve from that point forward.
However, once the recovery phase truly begins, it often becomes clear that healing does not move in a straight upward line. Instead, it tends to fluctuate — with good days and more difficult days.
Energy levels may rise and fall. Sleep may feel unstable. Heartbeats may seem more noticeable. Joints may feel stiff. Thinking may feel slower. Sensitivity to weather may increase.
These changes can feel confusing and sometimes discouraging. Yet in many cases, they reflect the body’s ongoing effort to regain balance.
After completing treatment, many people notice that their bodies do not feel as flexible as before.
Joints may feel particularly stiff in the morning, standing up after sitting for a long time may require a moment to “loosen up,” and movements such as bending or squatting can feel more restricted.
This experience is common during recovery and is usually caused by multiple physiological factors rather than a single issue.
After completing treatment, some individuals notice that they become more forgetful or that their thinking speed is not quite the same as before.
Familiar tasks may suddenly feel harder to recall, responses during conversations may seem slightly delayed, and maintaining focus while reading can become more challenging.
This experience is not uncommon during recovery and is often described as “brain fog.” For many people, it represents a temporary adjustment phase rather than a permanent change.